CCL5 and sarcopenia: These findings indicate that CCL5, through the CCR5 receptor, produces an imbalance between the processes of protein synthesis and degradation, upregulates the gene expression of E3 ligases associated with UPS, and decreases the rate of protein synthesis, contributing to the manifestation of a sarcopenia-like phenotype in muscle cells.